On this page

Rac 45 Cattle

Ractopamine Hydrochloride

Veterinary ANADA Approved 326 adverse event reports

Overview

Source: Animal Drugs @ FDA
Proprietary name
Rac 45 Cattle
Active ingredient
Ractopamine Hydrochloride
Application type
ANADA
Sponsor
Virbac AH, Inc.
Applications on record
1
First published
April 23, 2026

Adverse event reports

Source: openFDA VeDDRA
326
Reports mentioning this ingredient
May 15, 2009 – March 26, 2025
164
Classified serious
per reporter assessment
26
Lack of expected efficacy
resistance signal
9
Human operator exposure
needle-stick or splash
Not a risk measure. Veterinary adverse event reports are influenced by how many animals are treated, reporting practice and product age. Reports do not establish that the product caused the event, and a single report can cover an entire herd or flock. Attribution here is by active ingredient because the source dataset redacts brand names.

Attributed by active ingredient “RACTOPAMINE HYDROCHLORIDE”. Green Book ingredient names and VeDDRA ingredient names do not always agree exactly, so attribution is approximate and labelled as such.

Reported reactions

Source: openFDA VeDDRA

Clinical signs coded in the VICH VeDDRA four-level hierarchy, most frequent first.

Reaction terms reported for this ingredient, by report count.
Reaction (VeDDRA term) Reports Relative frequency
Death 99
Lameness 32
Behavioural disorder NOS 22
Distress 18
Ruminal bloat 18
Recumbency 14
Respiratory tract disorder NOS 14
Pneumonia 14
Uncoded sign 12
Digestive tract disorder NOS 12
Residues in meat/offal 12
Lack of efficacy - NOS 11
Other abnormal test result NOS 11
Loss of condition 10
Tachycardia 10
Death by euthanasia 9
Accidental exposure 9
Lethargy (see also Central nervous system depression in 'Neurological') 9
Bloated 9
Trauma NOS 8

Species affected

Source: openFDA VeDDRA
Cattle 180 Pig 104 Dog 10 Horse 7 Human 5 Turkey 4 Cat 1 Goat 1 Chicken 1

Regulatory context

Abbreviated New Animal Drug Application (ANADA). A generic animal drug demonstrating bioequivalence, pharmaceutical equivalence and identical manufacturing criteria to the pioneer application. Veterinary generics have no formal therapeutic-equivalence coding system; they match the pioneer NADA specification instead.

Extra-label use in food-producing animals is governed by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) and 21 CFR Part 530. It requires a valid veterinarian-client-patient relationship and is prohibited outright for certain drug classes. Withdrawal times are determined by FARAD, not by this index.

Sources for this page

Animal Drugs @ FDA FDA CVM Applications, sponsor, status, withdrawal
Animal & Veterinary Events FDA CVM VeDDRA adverse event aggregates by active ingredient